Idexx Laboratories (IDXX) Share-based Compensation (2009 - 2026)

Idexx Laboratories' Share-based Compensation history runs 18 years deep, the most recent figure standing at $16.3 million for Q1 2026.

• In Q1 2026, Share-based Compensation rose 11.8% year-over-year to $16.3 million; the TTM figure through Mar 2026 stood at $61.7 million (up 2.03% YoY), while the FY2025 annual figure was $60.0 million, changed 0.47% from the prior year.
• Share-based Compensation was $16.3 million for Q1 2026 at Idexx Laboratories, up from $16.1 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $16.3 million in Q1 2026 to a low of $11.2 million in Q1 2022.
• Historically, Share-based Compensation has averaged $14.5 million across 5 years, with a median of $14.6 million in 2025.
• The sharpest annual moves came in 2022 and 2025: Share-based Compensation jumped 36.71% in 2022, then retreated 9.33% in 2025.
• A 5-year view of Share-based Compensation shows it stood at $13.3 million in 2022, then advanced by 14.64% to $15.2 million in 2023, then slipped by 6.34% to $14.3 million in 2024, then rose by 13.0% to $16.1 million in 2025, then gained by 1.42% to $16.3 million in 2026.
• The last three Share-based Compensation figures came in at $16.3 million (Q1 2026), $16.1 million (Q4 2025), and $14.4 million (Q3 2025), per Business Quant data.